Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seqplexing
Paterna, Valencia, Spainseqplexing.com ↗
- Ownership
- Private
- Employees
- ~7
- Development stage
- Commercial
01
Overview
Seqplexing is an active Spanish biotechnology spin-off from INCLIVA Health Research Center specializing in high-value NGS-based genetic studies. It offers commercialized products based on its own patents for rapid detection of hereditary disease-causing variants, CNVs, somatic mutations, microbiome profiling, methylation studies, etc. The EOSAL platform is being further developed with academic partners to improve precision medicine applications in oncology. The company also leads or participates in collaborative projects on environmental monitoring and transplant rejection biomarkers.
- Therapeutic areas
- ImmunologyOncologyRare DiseasesGastroenterology
- Modalities
- DNA sequencingRNA sequencingMetagenomics (shotgun, 16S/18S rRNA)
- Industry
- Molecular Diagnostics
02
Partnerships
Lexogen reference laboratory for Spain & Portugal via Isogen Life Science partnershipUniversity of Valencia/I^2SysBio collaboration on EOSAL project & other R&D initiativesValencian Agency for Innovation-funded environmental monitoring consortium
Beyond the preview
Go deeper on Seqplexing.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Seqplexing.